bearsky23 / Shutterstock.com
After the “EU Summary of Clinical Trial Results for Laypersons” was published for consultation in June, a counsel from Novo Nordisk discussed the importance of providing reliable information for patients at an industry event in London.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Life Sciences Law Forum 2016, clinical trial data, EU Summary of Clinical Trial Results for Laypersons, Novo Nordisk
